Cosar, H. Et Al. 2017. Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study. Pediatric Drugs , vol.19, no.1 , 53-58.

Cosar, H., Isik, H., Cakır, S. Ç., Yar, N., Goksen, B., Tokbay, H., ... Kertmen, H.(2017). Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study. Pediatric Drugs , vol.19, no.1, 53-58.

Cosar, Hese Et Al. "Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study," Pediatric Drugs , vol.19, no.1, 53-58, 2017

Cosar, Hese Et Al. "Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study." Pediatric Drugs , vol.19, no.1, pp.53-58, 2017

Cosar, H. Et Al. (2017) . "Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study." Pediatric Drugs , vol.19, no.1, pp.53-58.

@article{article, author={Hese Cosar Et Al. }, title={Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study}, journal={Pediatric Drugs}, year=2017, pages={53-58} }